Patient P-02529

Synthetic patientMETA-24 · Day 168 · 35–44 · F · baseline S17Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S17
Day 21 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 21.

Primary contributors, last 14 days

GI instability-15
Inflammatory activity-9
Nutritional resilience+5
Treatment adherence-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

90 min

improving · +6.7 vs previous 14 d

Sleep duration

Wearable

8.4 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.6/10

improving · +0.6 vs previous 14 d

Steps

Wearable

9,827

improving · +620 vs previous 14 d

GI burden

Companion

9.3/100

improving · -8.3 vs previous 14 d

Adherence

Companion

90.7 %

stable · -3.3 vs previous 14 d

Sleep quality

Wearable

74.4/100

stable · +1.7 vs previous 14 d

Glucose, CGM daily mean

CGM

116 mg/dL

stable · -1.0 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 78 from the failing basin, 34 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -4.3 next day on high-intake days · n 24

Would not help

Keep histamine low
GI +2.3 next day on high-intake days · n 17

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.3supporter · 95%
Histamine load
+2.3detractor · 56%
Dietary fat load
+1.4no signal · 32%
Caffeine
-1no signal · 22%
Simple carbohydrates
+0.6no signal · 15%
Alcohol
+0.3no signal · 15%
Ultra-processed food
+0.2no signal · 15%
Insoluble fibre
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4.1 · butyrate capacity 76/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 41 ms
Sleep: 7.6 h
Steps: 8,215
Resting HR: 57 bpm

Daily log: GI score 9, nutritional resilience 69, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02082	44%	S12	NP-02	improved	53
P-02455	44%	S09	DT-01	improved	50
P-02339	43%	S03	DT-01	improved	50
P-02494	43%	S09	GI-04	improved	47
P-02303	42%	S15	GI-04	improved	48
P-02235	41%	S14	DT-01	improved	50
P-02064	40%	S04	SC-12	improved	57
P-02355	40%	S09	GI-04	improved	55
P-02518	40%	S17	DT-01	improved	68
P-02033	39%	S06	GI-04	improved	51
P-02150	39%	S11	HY-01	improved	45
P-02167	39%	S02	HY-01	improved	54